Early Detection of Lung Cancer Possible With New Biomarker
Investigators have found significantly higher levels of cytoskeleton-associated protein 4 (CKAP4) in the blood of patients with lung cancer than in healthy individuals. Moreover, the protein is sensitive enough to be detected in the patients'' blood as early as in stage I of non-small-cell lung cancer and squamous cell carcinoma, compared to current biomarkers. This could potentially make it a non-invasive diagnostic marker for specific lung cancers.
Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer